ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Breast Cancer 4 MedTech Companies Leading the Next Generation of Mammography with Artificial IntelligenceBy Veta ObazenuOctober 29, 2022Currently, even with more than 3.8 million breast cancer survivors in the United States, the disease is still the second-leading cause… Read More
Breast Cancer Concarlo Holdings Combats Resistant Metastatic Breast Cancer with Dual Receptor TherapeuticBy Veta ObazenuOctober 13, 2019Breast cancer is the most common cancer diagnosed among women. Over a lifetime, approximately 1 in 8 women develop breast… Read More
